Skip to content

Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction

Efficiency of Donepezil in Elderly Patients Undergoing Orthopedic Surgery Due to Underlying Postoperative Cognitive Dysfunction, a Multicenter Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04423276
Enrollment
360
Registered
2020-06-09
Start date
2020-06-14
Completion date
2022-12-01
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Head of Femur Articular Displaced, Protrusion of Intervertebral Disc, Total Knee Arthroplasty

Brief summary

Postoperative cognitive dysfunction (POCD) occurs mainly in aged patients. POCD may increase the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective therapy method was proved. According to our previous study, the central cholinergic system impaired by the anesthesia and surgery play a very important role in the POCD and donepezil an acetylcholinesterase inhibitor can prevent the POCD after isoflurane anesthesia in aged mice. Donepezil is a commercial medicine used for the Alzheimer Disease, which is tolerable and has minimal adverse events. In present study a multi-center randomized case control study was conducted and we hypothesized that donepezil attenuate the POCD.

Interventions

DRUGDonepezil

Donepezil a cholinesterase inhibitor, 5mg(1 pill)/ day for 7 days Po, was administrated from the day before surgery.

DRUGPlacebo

Placebo, 1 pill/ day for 7 days Po, was administrated from the day before surgery.

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
CollaboratorOTHER
Tenth People's Hospital of Tongji Univeristy
CollaboratorUNKNOWN
RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Elder than 60 years old 2. Speak Chinese Mandarin 3. Scheduled to undergo hip or knee replacement surgery and lumbar spine surgery 4. The operation time is more than 2 hours. 5. Signed the informed consent 6. American Society of Anesthesiologists (ASA) classification I-II

Exclusion criteria

1. Existing cerebral disease, or have a history of neurological and psychiatric diseases including Alzheimer Disease, stroke, epilepsy and psychosis 2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24 3. Several audition or vision disorder 4. Patients with tumors or infections 5. Unwillingness to comply with the protocol or procedures 6. Can not communicate normally in Mandarin Chinese 7. Existing bradycardiac arrhythmia (Heart rate \<60 bpm for any reasons) 8. Existing gastrointestinal ulcer 9. Existing urinary incontinence 10. Existing asthma or chronic obstructive pulmonary disease 11. Postoperative admission to ICU 12. Allergic to donepezil

Design outcomes

Primary

MeasureTime frame
The incidence of POCD after the surgery.up to 7 days

Secondary

MeasureTime frame
The incidence of postoperative delirium after surgery.1 to 7 days after surgery
POCD incidence one month, six months and one year after surgery.one month, six months and one year after surgery

Countries

China

Contacts

Primary ContactDiansan Su, M.D., Ph.D.
diansansu@yahoo.com+8618616514088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026